Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Chymotrypsin for Injection Market by Type (Powder, Particle, Other), By Application (Application I, Application II) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Chymotrypsin for Injection Market by Type (Powder, Particle, Other), By Application (Application I, Application II) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 132359 3300 Pharma & Healthcare 377 237 Pages 4.9 (36)

Market Overview:

The global chymotrypsin for injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for chymotrypsin for various applications, such as application I and application II. Chymotrypsin is a proteolytic enzyme that helps in the digestion of proteins. It is used as an ingredient in various food items and also has medical applications.

Global Chymotrypsin for Injection Industry Outlook

Product Definition:

Chymotrypsin for Injection is a proteolytic enzyme isolated from the pancreas. Chymotrypsin cleaves peptide bonds adjacent to certain amino acids, including tyrosine, phenylalanine and tryptophan. Chymotrypsin is used as a digestive aid to help digest proteins in the stomach.


Powder is a combination of chymotrypsinogen and other ingredients which are used as an alternative to the enzyme's activity. It can be formulated in various forms such as lyophilized, non-lyophilized, and ready to use solutions. Powder is majorly used for the treatment of dogs suffering from acute pancreatitis or chronic pancreatitis.


Particle and it's usage in Chymotrypsin for Injection market is used in the process of digestion by the body. The particles are basically used to enhance the absorption of chymotrypsinogen from stomach into blood and other tissues. It basically increases the amount of enzyme that can be utilized during a particular time period which ultimately improves digestive function.

Application Insights:

Application I accounted for the largest share of more than 60.0% in 2017. The application is majorly used to treat chronic kidney diseases and other disorders. Chronic Kidney Disease (CKD) is a condition in which the kidneys are not able to function properly over a period of time leading to increased blood flow through the kidneys and reduced urine output from the body tissues. Chymotrypsin for injection is widely used as an alternative therapy for treating patients with CKD as it helps remove waste products from cells, thus improving renal function naturally without any side effects or adverse reactions reported so far among patients undergoing treatment with this enzyme replacement therapy product globally.

Application II segment is expected to witness significant growth during forecast years due largely on increasing R&D initiatives by various companies operating in this sector including Pfizer, Merck & Co., Inc.

Regional Analysis:

North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its growth. In addition, new product launches and technological advancements are also expected to drive the regional market over the forecast period. For instance, in May 2018 Merck KGaA launched chymotrypsinogen IX (KYXnine) that is a purified form of chicken trypsin inhibitor under brand name KYNA gel for treatment of IBS-C (irritable bowel syndrome with constipation).

Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income leading to an increase in demand for medical products & services; growing geriatric population prone to chronic diseases; and increasing awareness about early diagnosis among patients.

Growth Factors:

  • Increasing demand for Chymotrypsin for Injection due to its therapeutic properties.
  • Rising prevalence of chronic diseases that can be treated with Chymotrypsin for Injection.
  • Growing awareness about the benefits of Chymotrypsin for Injection among patients and healthcare professionals.
  • Technological advancements in the manufacturing of Chymotrypsin for Injection products that improve their quality and efficacy.

Scope Of The Report

Report Attributes

Report Details

Report Title

Chymotrypsin for Injection Market Research Report

By Type

Powder, Particle, Other

By Application

Application I, Application II

By Companies

BIOZYM, Worthington Biochemical Corporation, Sigma-Aldrich, Shanghai Yaxin Biotechnology, Atlanta Biologicals, Sichuan Deebio Pharmaceutical, BeiJing Geyuantianrun Bio-tech, Shanghai Linzyme Biosciences, Zhejiang Fengan Biopharmaceutical, Gold Bio

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Chymotrypsin for Injection Market Report Segments:

The global Chymotrypsin for Injection market is segmented on the basis of:


Powder, Particle, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Application I, Application II

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  2. Worthington Biochemical Corporation
  3. Sigma-Aldrich
  4. Shanghai Yaxin Biotechnology
  5. Atlanta Biologicals
  6. Sichuan Deebio Pharmaceutical
  7. BeiJing Geyuantianrun Bio-tech
  8. Shanghai Linzyme Biosciences
  9. Zhejiang Fengan Biopharmaceutical
  10. Gold Bio

Global Chymotrypsin for Injection Market Overview

Highlights of The Chymotrypsin for Injection Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Powder
    2. Particle
    3. Other
  1. By Application:

    1. Application I
    2. Application II
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Chymotrypsin for Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Chymotrypsin for Injection Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Chymotrypsin is a serine protease enzyme that is used to dissolve proteins. It is most commonly used as an injection for the treatment of pancreatitis, cholangitis, and other diseases of the liver.

Some of the key players operating in the chymotrypsin for injection market are BIOZYM, Worthington Biochemical Corporation, Sigma-Aldrich, Shanghai Yaxin Biotechnology, Atlanta Biologicals, Sichuan Deebio Pharmaceutical, BeiJing Geyuantianrun Bio-tech, Shanghai Linzyme Biosciences, Zhejiang Fengan Biopharmaceutical, Gold Bio.

The chymotrypsin for injection market is expected to grow at a compound annual growth rate of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Chymotrypsin for Injection Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Chymotrypsin for Injection Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Chymotrypsin for Injection Market - Supply Chain
   4.5. Global Chymotrypsin for Injection Market Forecast
      4.5.1. Chymotrypsin for Injection Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Chymotrypsin for Injection Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Chymotrypsin for Injection Market Absolute $ Opportunity

5. Global Chymotrypsin for Injection Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Chymotrypsin for Injection Market Size and Volume Forecast by Type
      5.3.1. Powder
      5.3.2. Particle
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Chymotrypsin for Injection Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Chymotrypsin for Injection Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Chymotrypsin for Injection Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Chymotrypsin for Injection Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Chymotrypsin for Injection Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Chymotrypsin for Injection Demand Share Forecast, 2019-2029

9. North America Chymotrypsin for Injection Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Chymotrypsin for Injection Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Chymotrypsin for Injection Market Size and Volume Forecast by Type
      9.7.1. Powder
      9.7.2. Particle
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Chymotrypsin for Injection Demand Share Forecast, 2019-2029

10. Latin America Chymotrypsin for Injection Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Chymotrypsin for Injection Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Chymotrypsin for Injection Market Size and Volume Forecast by Type
      10.7.1. Powder
      10.7.2. Particle
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Chymotrypsin for Injection Demand Share Forecast, 2019-2029

11. Europe Chymotrypsin for Injection Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Chymotrypsin for Injection Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Chymotrypsin for Injection Market Size and Volume Forecast by Type
      11.7.1. Powder
      11.7.2. Particle
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
     11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Chymotrypsin for Injection Demand Share, 2019-2029

12. Asia Pacific Chymotrypsin for Injection Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Chymotrypsin for Injection Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Chymotrypsin for Injection Market Size and Volume Forecast by Type
      12.7.1. Powder
      12.7.2. Particle
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Chymotrypsin for Injection Demand Share, 2019-2029

13. Middle East & Africa Chymotrypsin for Injection Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Chymotrypsin for Injection Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Chymotrypsin for Injection Market Size and Volume Forecast by Type
      13.7.1. Powder
      13.7.2. Particle
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Chymotrypsin for Injection Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Chymotrypsin for Injection Market: Market Share Analysis
   14.2. Chymotrypsin for Injection Distributors and Customers
   14.3. Chymotrypsin for Injection Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. BIOZYM Overview Financials Developments Strategic Outlook
      14.4.2. Worthington Biochemical Corporation Overview Financials Developments Strategic Outlook
      14.4.3. Sigma-Aldrich Overview Financials Developments Strategic Outlook
      14.4.4. Shanghai Yaxin Biotechnology Overview Financials Developments Strategic Outlook
      14.4.5. Atlanta Biologicals Overview Financials Developments Strategic Outlook
      14.4.6. Sichuan Deebio Pharmaceutical Overview Financials Developments Strategic Outlook
      14.4.7. BeiJing Geyuantianrun Bio-tech Overview Financials Developments Strategic Outlook
      14.4.8. Shanghai Linzyme Biosciences Overview Financials Developments Strategic Outlook
      14.4.9. Zhejiang Fengan Biopharmaceutical Overview Financials Developments Strategic Outlook
      14.4.10. Gold Bio Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us